A Look At 10x Genomics (TXG) Valuation After New Collaborations And Revenue Above Guidance

Endpoints NewsRA, Forbion and Sanofi Ventures appear to back new eye drug from Korea

Endpoints NewsNovocure’s electric fields therapy fails key glioblastoma study

PharmaVoiceAs M&A rebounds, here’s how pharmas can prepare to seal a deal

FierceBiotechKardigan buttons up $400M upsized IPO to power heart drugs toward phase 3

FierceBiotechNovocure device fails to improve brain cancer patients’ survival in phase 3 test

FierceBiotechNortiva purrs into action with long-acting Lynx platform salvaged from Langer startup

Endpoints NewsInnoviva revives Lyndra's long-acting oral drug platform

FierceBiotechBiogen inks $1B RayThera buyout to bag preclinical immunology assets

Endpoints NewsModerna adds commercial chief, expands Stephen Hoge's role; Reunion Neuroscience CEO departs

Endpoints NewsEli Lilly's TuneLab hits 100 members, adding Chai's AI models

CellChloroplast sunscreening by protein condensates confers high-light tolerance

PharmaVoiceA new Westlake-backed biotech takes aim at migraines